Phlow Corp. Applauds Executive Action to Operationalize the Strategic Active Pharmaceutical Ingredient Reserve (SAPIR)

Phlow Corp. Applauds Executive Action to Operationalize the Strategic Active Pharmaceutical Ingredient Reserve (SAPIR)

RICHMOND, Va, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American...

Trump Signs Executive Order to Fill Reserve with Critical Drugs

by Natalia Mittelstadt   President Trump has signed an executive order to fill the Strategic Active Pharmaceutical Ingredients Reserve with critical drugs to ensure “a resilient domestic supply chain for essential medicines.” The executive order signed on Tuesday directs the Department of Health and Human Services assistant secretary for Preparedness and Response to create a list of about 26 critical drugs that are deemed “vital to national heal…

Trump signs executive order to fill reserve with critical drugs

The executive order directs the Department of Health and Human Services Assistant Secretary for Preparedness and Response to create a list of about 26 critical drugs

Trump Signs Order to Refill Strategic Reserves of Pharmaceutical Ingredients

WASHINGTON—President Donald Trump signed an executive order on Aug. 13 to enhance American drug supply chain resilience by filling and maintaining the strategic reserve for essential pharmaceutical ingredients, with a preference for American-made ingredients—a move designed to push production away from dependency on China-made ingredients. “Nearly two-in-five prescription finished drug products are made in the United States, including many of th…

Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose.

Trump Executive Order Targets Domestic API Stockpile to Strengthen US Pharmaceutical Supply Chain

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential medicines list, and prioritizing US-made APIs.